Inventor · disambiguated record
Aviv Gazit
Also filed as: GAZIT AVIV · LEVITZKI ALEX · SLAMON DENNIS
29 granted patents·5 pending applications·2,220 citations·filing 1991–2013
98Inventor score
Files withYISSUM RES DEV CO8SUGEN INC7MAX PLANCK GESELLSCHAFT3BEN-GURION UNIV OF THE NEGEV RES AND DEV AUTHORITY2NOTOX LTD2
Top patents by PatentIndex Score
34 records- 0199US5217999AStyryl compounds which inhibit EGF receptor protein tyrosine kinaseYISSUM RES DEV CO·Filed 1992·Granted Jun 8, 1993·302 cites·21 claims
- 0298US5789427AMethods and compositions for inhibiting cell proliferative disordersSUGEN INC·Filed 1995·Granted Aug 4, 1998·264 cites·16 claims
- 0398US5773476AMethods and compositions for inhibiting cell proliferative disordersSUGEN INC·Filed 1995·Granted Jun 30, 1998·153 cites·17 claims
- 0498US5712395ACompounds for the treatment of disorders related to vasculogenesis and/or angiogenesisYISSUM RES DEV CO·Filed 1995·Granted Jan 27, 1998·118 cites·1 claims
- 0597US5763441ACompounds for the treatment of disorders related to vasculogenesis and/or angiogenesisSUGEN INC·Filed 1995·Granted Jun 9, 1998·111 cites·4 claims
- 0697US5196446ACertain indole compounds which inhibit EGF receptor tyrosine kinaseYISSUM RES DEV CO·Filed 1991·Granted Mar 23, 1993·101 cites·15 claims
- 0795US5990141ATreatment of platelet derived growth factor related disorders such as cancersSUGEN INC·Filed 1995·Granted Nov 23, 1999·189 cites·20 claims
- 0895US5851999AFLK-1 is a receptor for vascular endothelial growth factorMAX PLANCK GESELLSCHAFT·Filed 1995·Granted Dec 22, 1998·160 cites·32 claims
- 0995US5792771AQuinazoline compounds and compositions thereof for the treatment of diseaseSUGEN INC·Filed 1995·Granted Aug 11, 1998·155 cites·12 claims
- 1091US6331555B1Treatment of platelet derived growth factor related disorders such as cancersUNIV CALIFORNIA·Filed 1999·Granted Dec 18, 2001·152 cites·15 claims
- 1190US6596878B2Methods and compositions for inhibiting cell proliferative disordersYISSUM RES & DEV COMPANY OF TH·Filed 2001·Granted Jul 22, 2003·26 cites·11 claims
- 1290US5656655AStyryl-substituted heteroaryl compounds which inhibit EGF receptor tyrosine kinaseRHONE-POULENC INC·Filed 1995·Granted Aug 12, 1997·50 cites·10 claims
- 1388US5981569ASubstituted phenylacrylonitrile compounds and compositions thereof for the treatment of diseaseYISSUM RES DEV CO·Filed 1995·Granted Nov 9, 1999·86 cites·16 claims
- 1488US5932580APDGF receptor kinase inhibitory compounds their preparation and compositionsYISSUM RES DEV CO·Filed 1997·Granted Aug 3, 1999·95 cites·15 claims
- 1588US5849742ACompounds for the treament of disorders related to vasculogenesis and/or angiogenesisSUGEN INC·Filed 1997·Granted Dec 15, 1998·28 cites·14 claims
- 1688US5700822ATreatment of platelet derived growth factor related disorders such as cancersUNIV CALIFORNIA·Filed 1995·Granted Dec 23, 1997·67 cites·24 claims
- 1782US8609736B2Telomerase activating compounds and methods of use thereofGAZIT AVIV·Filed 2008·Granted Dec 17, 2013·7 cites·13 claims
- 1882US8604245B2Tri-aryl compounds and compositions comprising the samePRIEL ESTHER·Filed 2008·Granted Dec 10, 2013·7 cites·10 claims
- 1981US6126917AEpidermal growth factor receptor binding compounds for positron emission tomographyHADASIT MED RES SERVICE·Filed 1999·Granted Oct 3, 2000·62 cites·9 claims
- 2078US6872699B2Truncated Flk-1 receptor protein, methods of use and a recombinant vector containing a nucleotide encoding the truncated Flk-1 proteinMAX PLANCK GESELLSCHAFT·Filed 2001·Granted Mar 29, 2005·6 cites·4 claims
- 2177US9663448B2Tri-aryl compounds and compositions comprising the sameBEN-GURION UNIV OF THE NEGEV RES AND DEV AUTHORITY·Filed 2013·Granted May 30, 2017·2 cites·4 claims
- 2276US5677329AStyryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit EGF receptor tyrosine kinaseRHONE POULENC RORER PHARMA·Filed 1995·Granted Oct 14, 1997·15 cites·16 claims
- 2375US9670139B2Telomerase activating compounds and methods of use thereofBEN-GURION UNIV OF THE NEGEV RES AND DEV AUTHORITY·Filed 2013·Granted Jun 6, 2017·2 cites·5 claims
- 2474US6673798B2PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including sameYISSUM RES DEV CO·Filed 2001·Granted Jan 6, 2004·10 cites·31 claims
- 2572US7217737B2Method and compositions for inhibiting cell proliferative disordersSUGEN INC·Filed 2003·Granted May 15, 2007·3 cites·15 claims
- 2660US6358954B1PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including sameYISSUM RES DEV CO·Filed 1999·Granted Mar 19, 2002·16 cites·20 claims
- 2757US7964399B2Cell line comprising vector encoding truncated FLK-1 receptorMAX PLANCK GESELLSCHAFT·Filed 2004·Granted Jun 21, 2011·1 cites·2 claims
- 2856US6426366B1Pharmaceutical compositions comprising tyrphostinsNOTOX LTD·Filed 1997·Granted Jul 30, 2002·19 cites·13 claims
- 2951USRE38761EStyryl compounds which inhibit EGF receptor protein tyrosine kinaseYISSUM RES DEV CO·Filed 1994·Granted Jul 19, 2005·13 cites·32 claims
- 3048US2004132725A1PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including sameFiled 2003·Application pending·0 cites
- 3143US2005143430A1Catechol bioisosteresFiled 2004·Application pending·0 cites
- 3242US2003013748A1Pharmaceutical compositions comprising tyrphostinsNOTOX LTD·Filed 2002·Application pending·0 cites
- 3337US2004197335A1Non-myeloablative tolerogenic treatment with tyrphostinsFiled 2002·Application pending·0 cites
- 3423US2001051628A1Methods to modulate the resistance of cells to apoptosis mediated by mutant epidermal growth factor receptorsFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Aviv Gazit files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →